Grace Therapeutics, Inc. Goodwill in USD from Q1 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Grace Therapeutics, Inc. quarterly Goodwill history and growth rate from Q1 2022 to Q3 2025.
  • Grace Therapeutics, Inc. Goodwill for the quarter ending September 30, 2025 was $8.14M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)

Grace Therapeutics, Inc. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $8.14M $0 0% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $8.14M $0 0% Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $8.14M $0 0% Mar 31, 2025 10-Q 2025-11-13
Q4 2024 $8.14M $0 0% Dec 31, 2024 10-Q 2025-02-13
Q3 2024 $8.14M $0 0% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $8.14M $0 0% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $8.14M $0 0% Mar 31, 2024 10-K 2025-06-23
Q4 2023 $8.14M -$4.83M -37.2% Dec 31, 2023 10-Q 2024-02-12
Q3 2023 $8.14M -$4.83M -37.2% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $8.14M -$4.83M -37.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $8.14M -$4.83M -37.2% Mar 31, 2023 10-K 2025-06-23
Q4 2022 $13M Dec 31, 2022 10-Q 2023-02-14
Q3 2022 $13M Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $13M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $13M Mar 31, 2022 10-K 2024-06-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.